Edwards Lifesciences Corporation EW NYSE

NYSE • Healthcare • Medical - Devices • US • USD

SharesGrow Score

74/100

6/7 Pass

SharesGrow Intrinsic Value

Edwards Lifesciences Corporation (EW) has 20 已知的内部人和机构持有人记录. 最大持有人为 Lemercier Jean-Luc M 持有 184,686 股. 其他重要持有人包括 WANG HUIMIN 和 Szyman Catherine M..

过去12个月，内部人进行了 90 笔交易，涉及 EW 股票 — 26 笔买入 (价值为 $423.15K) 和 14 笔卖出 (价值为 $7.49M). 内部人买入超过卖出，可能表明对公司前景有信心.

EW 內部人持股

最大持股人

Lemercier Jean-Luc M

184,686 股

买入（12个月）

$423.15K 价值

卖出（12个月）

$7.49M 价值

12个月交易活动

买入 29%

卖出 16%

主要內部人持股

#	姓名	职位	持股数量	最近申报日期	相对规模
1	Lemercier Jean-luc M	CVP, Emeacla and Japac	184,686	2024-07-08	100%
2	Wang Huimin	CVP, Japan & Intercontinental	99,381	2022-07-08	54%
3	Szyman Catherine M.	CVP, Critical Care	81,287	2024-09-03	44%
4	Valeriani Nicholas J	Director	79,296	2025-05-09	43%
5	Loranger Steven R	Director	63,900	2025-05-09	35%
6	Wood Larry L	Global President Tavr & Surg	35,800	2025-08-18	19%
7	Chopra Daveen	CVP, Tmtt & Surgical	32,201	2025-12-11	17%
8	Marsh Martha H.	Director	31,880	2023-05-15	17%
9	Stone Heisz Leslie	Director	30,948	2025-12-12	17%
10	Ullem Scott B.	CVP, Chief Financial Officer	26,000	2026-03-11	14%
11	Bobo Donald E Jr	CVP,strategy/corp Development	21,266	2026-03-02	12%
12	Markowitz Wayne	CVP, Japac	17,563	2025-12-08	10%
13	Sellers Robert W.a.	SVP, Corporate Controller	17,081	2024-05-13	9%
14	Laviolette Paul A	Director	14,301	2025-05-09	8%
15	Bruls Annette	CVP, Emeacla	14,171	2025-07-11	8%
16	Sequeira Ramona	Director	11,686	2025-05-09	6%
17	Zovighian Bernard J	CEO	11,517	2026-02-13	6%
18	Dahl Andrew M.	SVP, Corporate Controller	9,089	2026-02-23	5%
19	Davis Leslie C.	Director	6,583	2025-05-09	4%
20	Feinberg David T	Director	5,836	2025-05-09	3%

近期交易 (过去12个月)

日期	姓名	职位	类型	股数	股价	总价值
2026-04-06	Lippis Daniel J.	CVP, Tavr	期权行权（卖出）	1,019	$59.26	$60.38K
2026-04-02	Bobo Donald E Jr	CVP,strategy/corp Development	期权行权（卖出）	22,680	$59.26	$1.34M
2026-03-11	Lippis Daniel J.	CVP, Tavr	期权行权（卖出）	1,019	$59.26	$60.38K
2026-03-11	Ullem Scott B.	CVP, Chief Financial Officer	期权行权（卖出）	13,000	$59.26	$770.34K
2026-03-02	Bobo Donald E Jr	CVP,strategy/corp Development	知情卖出	11,340	$85.93	$974.43K
2026-02-25	Bobo Donald E Jr	CVP,strategy/corp Development	知情卖出	24,000	$83.84	$2.01M
2026-02-22	Dahl Andrew M.	SVP, Corporate Controller	RSU 预扣税	176	$79.78	$14.04K
2026-02-22	Lippis Daniel J.	CVP, Tavr	RSU 预扣税	432	$79.78	$34.46K
2026-02-17	Lippis Daniel J.	CVP, Tavr	RSU 预扣税	198	$75.87	$15.02K
2026-02-16	Lippis Daniel J.	CVP, Tavr	RSU 预扣税	258	$75.87	$19.57K
2026-02-12	Lippis Daniel J.	CVP, Tavr	限制性股票授予 (RSU)	12,820	-	-
2026-02-16	Ullem Scott B.	CVP, Chief Financial Officer	RSU 预扣税	199	$75.87	$15.1K
2026-02-13	Zovighian Bernard J	CEO	赠与（收到）	2,920	-	-
2026-02-12	Zovighian Bernard J	CEO	期权行权（卖出）	25,350	$59.26	$1.5M
2026-01-09	Lippis Daniel J.	CVP, Tavr	期权行权（卖出）	1,019	$59.26	$60.38K
2026-01-06	Bobo Donald E Jr	CVP,strategy/corp Development	知情卖出	8,708	$85.98	$748.71K
2025-12-12	Lippis Daniel J.	CVP, Japac	期权行权（卖出）	1,019	$59.26	$60.38K
2025-12-12	Stone Heisz Leslie	Director	知情卖出	2,615	$83.41	$218.12K
2025-12-12	Bobo Donald E Jr	CVP,strategy/corp Development	赠与（送出）	7,100	-	-
2025-12-11	Chopra Daveen	CVP, Tmtt & Surgical	知情卖出	2,000	$84.38	$168.75K
2025-12-10	Zovighian Bernard J	CEO	知情卖出	3,863	$83.45	$322.37K
2025-12-09	Zovighian Bernard J	CEO	赠与（收到）	3,863	-	-
2025-12-08	Zovighian Bernard J	CEO	期权行权（卖出）	25,350	$59.26	$1.5M
2025-12-10	Bobo Donald E Jr	CVP,strategy/corp Development	期权行权（卖出）	11,340	$59.26	$671.97K
2025-12-09	Ullem Scott B.	CVP, Chief Financial Officer	期权行权（卖出）	7,700	$59.26	$456.28K